Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josep Redon

Showing results (171-180 of 271) with videos related to

Pageof 28
Sort By:
Journal of Clinical Medicine|June 19, 2020
Impact of Acute Hemoglobin Falls in Heart Failure Patients: A Population StudyCristina Lopez, Jose Luis Holgado, Antonio Fernandez, et al.
Journal of the American College of Cardiology|December 24, 2011
Safety and efficacy of low blood pressures among patients with diabetes: subgroup analyses from the ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial)Josep Redon, Giuseppe Mancia, Peter Sleight, et al.
Antioxidants & Redox Signaling|January 22, 2015
Do genes modify the association of selenium and lipid levels?Inmaculada Galan-Chilet, Eliseo Guallar, J Carlos Martin-Escudero, et al.
Antioxidants (Basel, Switzerland)|December 23, 2023
Traffic Density Exposure, Oxidative Stress Biomarkers and Plasma Metabolomics in a Population-Based Sample: The Hortega StudyLaura Sanchez-Rodriguez, Marta Galvez-Fernandez, Ayelén Rojas-Benedicto, et al.
Plos One|March 8, 2012
Common variants of the liver fatty acid binding protein gene influence the risk of type 2 diabetes and insulin resistance in Spanish populationMaria Luisa Mansego, Fernando Martínez, Maria Teresa Martínez-Larrad, et al.
European Journal of Internal Medicine|April 20, 2023
High miR-126-3p levels associated with cardiovascular events in a general populationOlga Martinez-Arroyo, Ana Ortega, Ana Flores-Chova, et al.
European Heart Journal. Cardiovascular Imaging|October 5, 2017
Non-invasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: A consensus paper from the European Association of Cardiovascular Imaging (EACVI), the European Society of Cardiology Council on Hypertension, and the European Society of Hypertension (ESH)Pasquale Perrone-Filardi, Antonio Coca, Maurizio Galderisi, et al.
Journal of Hypertension|August 3, 2017
Noninvasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: a consensus article from the European Association of Cardiovascular Imaging, the European Society of Cardiology Council on Hypertension and the European Society of HypertensionPasquale Perrone-Filardi, Antonio Coca, Maurizio Galderisi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 23, 2018
Immune-unreactive urinary albumin as a predictor of cardiovascular events: the Hortega StudyFernando Martínez, Gernot Pichler, Adrian Ruiz, et al.
European Heart Journal|June 7, 2018
Achieved diastolic blood pressure and pulse pressure at target systolic blood pressure (120-140 mmHg) and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trialsMichael Böhm, Helmut Schumacher, Koon K Teo, et al.
Pageof 28

Showing results (171-180 of 271) with videos related to

Sort By:
Pageof 28
Journal of Clinical Medicine|June 19, 2020
Impact of Acute Hemoglobin Falls in Heart Failure Patients: A Population StudyCristina Lopez, Jose Luis Holgado, Antonio Fernandez, et al.
Journal of the American College of Cardiology|December 24, 2011
Safety and efficacy of low blood pressures among patients with diabetes: subgroup analyses from the ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial)Josep Redon, Giuseppe Mancia, Peter Sleight, et al.
Antioxidants & Redox Signaling|January 22, 2015
Do genes modify the association of selenium and lipid levels?Inmaculada Galan-Chilet, Eliseo Guallar, J Carlos Martin-Escudero, et al.
Antioxidants (Basel, Switzerland)|December 23, 2023
Traffic Density Exposure, Oxidative Stress Biomarkers and Plasma Metabolomics in a Population-Based Sample: The Hortega StudyLaura Sanchez-Rodriguez, Marta Galvez-Fernandez, Ayelén Rojas-Benedicto, et al.
Plos One|March 8, 2012
Common variants of the liver fatty acid binding protein gene influence the risk of type 2 diabetes and insulin resistance in Spanish populationMaria Luisa Mansego, Fernando Martínez, Maria Teresa Martínez-Larrad, et al.
European Journal of Internal Medicine|April 20, 2023
High miR-126-3p levels associated with cardiovascular events in a general populationOlga Martinez-Arroyo, Ana Ortega, Ana Flores-Chova, et al.
European Heart Journal. Cardiovascular Imaging|October 5, 2017
Non-invasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: A consensus paper from the European Association of Cardiovascular Imaging (EACVI), the European Society of Cardiology Council on Hypertension, and the European Society of Hypertension (ESH)Pasquale Perrone-Filardi, Antonio Coca, Maurizio Galderisi, et al.
Journal of Hypertension|August 3, 2017
Noninvasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: a consensus article from the European Association of Cardiovascular Imaging, the European Society of Cardiology Council on Hypertension and the European Society of HypertensionPasquale Perrone-Filardi, Antonio Coca, Maurizio Galderisi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 23, 2018
Immune-unreactive urinary albumin as a predictor of cardiovascular events: the Hortega StudyFernando Martínez, Gernot Pichler, Adrian Ruiz, et al.
European Heart Journal|June 7, 2018
Achieved diastolic blood pressure and pulse pressure at target systolic blood pressure (120-140 mmHg) and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trialsMichael Böhm, Helmut Schumacher, Koon K Teo, et al.
Pageof 28